Feb 28, 2023 | Antithrombotics
1b) This is a #journalclub review of an excellent article published in late 2022 in @JAMANetworkOpen 🔓 https://t.co/qoP1gddS4o. 👏to @darae_ko et al for such an important look at this topic that is only gaining in importance as the population ages.#CardioTwitter...
Feb 19, 2023 | Antithrombotics
2) This program is supported by an educational grant from AstraZeneca & is intended for an audience of #healthcare providers. Statement of accreditation & faculty disclosures https://t.co/gvXca4G9Xm. Prior programs, still available for CE/#CME credit, at...
Jan 25, 2023 | Antithrombotics
1b) This is a #journalclub review of an excellent article published in late 2022 in J Manag Care Spec Pharm 🔓 https://t.co/nKfAvbrmNB.👏to @ihdezdelso et al for an insightful study on a topic only gaining in importance as the population ages....
Jan 9, 2023 | Antithrombotics
2) This 🆓program is accredited for 0.5h CE/#CME for #physicians #physicianassociates #nurses #nurespractitioners #pharmacists and is supported by a grant from AstraZeneca. See statement of accreditation and faculty disclosures at https://t.co/gvXca4G9Xm.—...
Dec 22, 2022 | Antithrombotics
2) I am Deborah Siegal MD MSc FRCOC @DebSiegal, a #hematologist @OttawaHospital, Tier 2 Canada Research Chair in Anticoagulant Management of Cardiovascular Disease, Associate Professor/Associate Scientist @uottawa pic.twitter.com/by15AJU9NP— cardio-met (@cardiomet_CE)...
Dec 12, 2022 | Antithrombotics
2) The outstanding faculty for this course included Thorsten Steiner (chair), Michiel Coppens, and Adrian Parry-Jones @adrianpj1. This #tweetorial recaps the questions directed to the faculty by the learned audience at the #ESOC22 presentation....